Genmab: Number of Employees 2019-2022 | GMAB

Interactive chart of Genmab (GMAB) annual worldwide employee count from 2019 to 2022.
  • Genmab total number of employees in 2021 was 1,212, a 55.19% increase from 2020.
  • Genmab total number of employees in 2020 was 781, a 42.52% increase from 2019.
  • Genmab total number of employees in 2019 was 548, a 30.79% increase from 2018.
  • Genmab total number of employees in 2018 was 419, a INF% increase from .
Genmab Annual Number of Employees
2021 1,212
2020 781
2019 548
2018 419
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $20.430B $1.349B
Genmab A/S is a biotechnology company. It specializes in development of antibody therapeutics for the treatment of cancer. The company's product pipeline includes DARZALEX(R), Arzerra(R), tisotumab vedotin, enapotamab vedotin, HexaBody-DR5/DR5(R) and DuoBody-CD3xCD20 (R),which are in clinical stage. Genmab A/S is based in Copenhagen V, Denmark.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $162.213B 9.87
Bio-Rad Laboratories (BIO.B) United States $15.121B 32.79
QIAGEN (QGEN) Netherlands $10.280B 16.23
Biohaven Pharmaceutical Holding (BHVN) United States $10.017B 0.00
Ginkgo Bioworks Holdings (DNA) United States $4.593B 0.00
Emergent Biosolutions (EBS) United States $1.775B 7.60
Arcus Biosciences (RCUS) United States $1.357B 34.40
Myovant Sciences (MYOV) United Kingdom $1.000B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.486B 0.00
Gelesis Holdings (GLS) United States $0.360B 0.00
Zymeworks (ZYME) Canada $0.346B 0.00
Ambrx Biopharma (AMAM) United States $0.149B 0.00
Enzo Biochem (ENZ) United States $0.116B 23.80
SQZ Biotechnologies (SQZ) United States $0.099B 0.00